Long-term positive severe acute respiratory syndrome coronavirus 2 ribonucleic acid and therapeutic effect of antivirals in patients with coronavirus disease: Case reports
Abstract Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a pandemic. We herein report four COVID-19 cases with long-term positive viral ribonucleic acid (RNA) for about 61 days. Despite treatment with recombinant human int...
Main Authors: | Bo Wei, Xiaofeng Hang, Ying Xie, Yuanjing Zhang, Jianrong Wang, Xinghao Cao, Jinzi J. Wu, Junxue Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical (SBMT)
2020-07-01
|
Series: | Revista da Sociedade Brasileira de Medicina Tropical |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822020000100720&tlng=en |
Similar Items
-
Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
by: Yassmin Moatasim, et al.
Published: (2023-11-01) -
Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2
by: Ahmed Kandeil, et al.
Published: (2021-06-01) -
Therapeutic approaches against coronaviruses acute respiratory syndrome
by: Camilla Servidio, et al.
Published: (2021-02-01) -
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
by: Ahmed Mostafa, et al.
Published: (2020-12-01) -
Antiviral Drugs Screening for Swine Acute Diarrhea Syndrome Coronavirus
by: Yangzhen Chen, et al.
Published: (2022-09-01)